1-6 of 6
Marcie J. Hursting
Close
Sort by
Journal Articles

Dosing Patterns and Outcomes in African American, Asian, and Hispanic Patients with Heparin-Induced Thrombocytopenia Treated with Argatroban.

Marcie J Hursting, PhD, Ik-Kyung Jang, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3403.
https://doi.org/10.1182/blood.V112.11.3403.3403
Published: 2008
Journal Articles

Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Obese, Versus Non-Obese, Patients.

Lawrence Rice, MD, Marcie J. Hursting, PhD, David A. McCollum, MS
Journal: Blood
Blood (2006) 108 (11): 1494.
https://doi.org/10.1182/blood.V108.11.1494.1494
Published: 2006
Journal Articles

Argatroban Anticoagulation for Heparin-Induced Thrombocytopenia in Elderly Patients.

John R. Bartholomew, MD, Carolynn E. Pietrangeli, Phd, Marcie J. Hursting, PhD
Journal: Blood
Blood (2006) 108 (11): 4104.
https://doi.org/10.1182/blood.V108.11.4104.4104
Published: 2006
Journal Articles

How Frequently Is Venous Thromboembolism in Heparin-Treated Patients Associated with Heparin-Induced Thrombocytopenia?.

Marcie J. Hursting, PhD, David McCollum, MS, Robert L. Levine, MD
Journal: Blood
Blood (2005) 106 (11): 3018.
https://doi.org/10.1182/blood.V106.11.3018.3018
Published: 2005
Journal Articles

Heparin-Induced Thrombocytopenia from Venous Thromboembolism Treatment.

Susan M. Begelman, MD, Marcie J. Hursting, PhD, Richard V. Aghababian, MD, David McCollum, MS
Journal: Blood
Blood (2005) 106 (11): 908.
https://doi.org/10.1182/blood.V106.11.908.908
Published: 2005
Journal Articles

No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin

Roy R. Hantgan, W. Gray Jerome, Marcie J. Hursting
Journal: Blood
Blood (1998) 92 (6): 2064–2074.
https://doi.org/10.1182/blood.V92.6.2064
Published: 1998